March 16th 2023
Researchers investigated sleep disturbances in individuals at ultra-high risk of psychosis.
February 17th 2023
Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person ApproachJanuary 23rd 2023
Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.
Phase 3 Trial of Dexmedetomidine for Bipolar I or II, Schizophrenia Doses First ParticipantsNovember 30th 2022
The phase 3 SERENITY III trial investigating at-home use of dexmedetomidine (BXCL501) sublingual film for agitation associated with bipolar I or II disorder or schizophrenia has started.
The Cross-Cultural Dimensions of PsychosisNovember 11th 2022
All medical students, psychiatry residents, fellows, faculty at academic medical institutions, and psychiatrists in independent practice must develop skills in cultural competence to avoid perpetuating disparities in health outcomes for BIPOC individuals with serious mental illnesses.